9/16/2022 2:05:25 AM
AstraZeneca PLC Says Beyfortus Recommended For Approval In The EU By CHMP
9/5/2022 2:20:19 AM
Sanofi Presents Phase 3 Open-label Extension Trial Results Of Dupixen At ERS 2022
8/30/2022 1:32:36 AM
Sanofi: FDA Grants Priority Review To Efanesoctocog Alfa For People With Hemophilia A
8/26/2022 8:03:11 AM
Sanofi Says Higher Dose Flu Vaccines Preferentially Recommended For Adults 65+ In CDC Morbidity &Mortality Weekly Report
8/17/2022 1:33:38 AM
Sanofi Discontinuing Clinical Development Program Of Amcenestrant, An Oral Selective Estrogen Receptor Degrader
7/28/2022 1:33:09 AM
Sanofi Q2 Business EPS EUR 1.73; IFRS EPS EUR 0.94
7/21/2022 1:21:29 AM
Innate Pharma Says Sanofi Made Decision To Progress IPH6401/SAR'514 Into IND-enabling Studies
7/10/2022 11:32:49 AM
Sanofi And Swedish Orphan Biovitrum Presents Positive Results From XTEND-1 Pivotal Phase 3 Study
7/10/2022 11:31:46 AM
Sanofi Presents Positive Data From Phase 3 ATLAS-PPX Study Of Fitusiran In Hemophilia A Or B With/without Inhibitors